Does Oscar Health Cover Viagra? A Complete 2025 Insurance Guide

What Is Oscar Health and How Does Its Drug Formulary Work?

Oscar Health is a tech-forward health insurance carrier operating in more than 20 states across individual, small-group, and employer-sponsored markets. Like every ACA-compliant insurer, Oscar uses a tiered drug formulary that places medications into cost brackets, typically Tier 1 (generic) through Tier 4 or 5 (specialty). The tier assigned to a drug determines what you pay at the pharmacy, whether a prior authorization (PA) is needed, and whether quantity limits apply.

The formulary is not uniform across all Oscar products. An Oscar individual marketplace plan purchased in Texas may have a different sildenafil tier than an employer-sponsored Oscar plan in Florida. Oscar publishes plan-specific formularies on its website and through the federal Health Insurance Marketplace. Checking the specific plan's Summary of Benefits and Coverage (SBC) and drug formulary before enrolling is the most reliable way to confirm coverage for any medication. The FDA maintains a database of approved drug products that insurers use as a baseline reference when building formularies. [1]

Sildenafil was granted FDA approval for erectile dysfunction in March 1998 under the brand name Viagra. [2] The Pfizer patent expired in 2017, and multiple generic manufacturers entered the market immediately, dropping retail prices by more than 90 percent. Most commercial insurers, including Oscar, responded by placing generic sildenafil on their formularies while simultaneously excluding brand-name Viagra as a "lifestyle drug." This distinction is the single most important fact to understand before calling Oscar's member services line.

Does Oscar Health Cover Sildenafil (Generic Viagra)?

Generic sildenafil is listed on many Oscar Health formularies, but coverage is not guaranteed on every plan. On plans where it appears, sildenafil typically lands at Tier 2 or Tier 3, carrying a copay of $10, $60 per fill after the deductible is met. Prior authorization is a standard requirement on most plans, meaning a clinician must submit medical documentation to Oscar before the pharmacy can process the claim.

The Endocrine Society's 2018 clinical practice guideline on male hypogonadism notes that ED is frequently a comorbidity of hormonal and metabolic conditions, underscoring the medical (not merely "lifestyle") basis for PDE5 inhibitor therapy in many patients. [3] When a clinician frames the PA request around an underlying medical diagnosis, such as diabetes-related vasculopathy, post-prostatectomy ED, or cardiovascular disease, approval rates are meaningfully higher than when ED is documented in isolation.

Data from the CDC's National Health and Nutrition Examination Survey show that ED prevalence reaches 77.5 percent in men with diabetes compared with roughly 30 percent in the general male population. [4] That degree of medical burden strengthens the clinical argument for coverage under most Oscar plans. Physicians requesting PA should document the specific comorbid diagnosis, prior treatment attempts, and the clinical rationale for sildenafil specifically, because Oscar's PA reviewers follow AUA (American Urological Association) evidence-based guidelines when evaluating requests. [5]

The three-step framework HealthRX clinicians use when helping patients get Oscar to approve sildenafil:

1. Confirm sildenafil appears on the plan's formulary by downloading the current year's drug list from Oscar's website or CMS's formulary database.
2. Have the prescribing clinician submit a PA request citing the specific ICD-10 diagnosis (N52.x for ED, or an underlying comorbidity), prior treatment history, and referenced AUA guideline support.
3. If denied, file a Level 1 internal appeal within 180 days of the denial notice, attaching peer-reviewed literature such as the 2018 AUA ED guideline update. [5]

Does Oscar Cover Brand-Name Viagra?

Brand-name Viagra (sildenafil citrate 25 mg, 50 mg, 100 mg manufactured by Pfizer) is excluded from coverage on nearly all Oscar commercial and marketplace plans. Most Oscar plan documents list Viagra explicitly under the "excluded drugs" or "non-covered services" section alongside other medications categorized as cosmetic or lifestyle-related.

The ACA's essential health benefits (EHBs) framework does not include ED medications as a required covered category. [6] Insurers are therefore free to exclude them, and most do for the brand product. The CMS essential health benefits final rule published in the Federal Register confirms that states may define benchmark plans that omit sexual dysfunction drugs entirely. [7]

The exception is pulmonary arterial hypertension. Sildenafil under the brand Revatio (20 mg tablets, three times daily) carries FDA approval for PAH, a life-threatening cardiopulmonary condition. [8] Oscar covers Revatio for PAH under standard medical necessity criteria because PAH is not classified as a lifestyle condition. If a patient has both PAH and ED, the PAH coverage pathway applies to Revatio, though the dosing regimen (20 mg three times daily) differs from the ED regimen (25 to 100 mg as needed).

Prior Authorization: What Oscar Requires and How Long It Takes

Prior authorization for sildenafil at Oscar typically takes 1, 3 business days for a standard review. Urgent PA requests, submitted when a patient has a time-sensitive clinical need, must be processed within 72 hours under federal regulations governing utilization management. [9]

Oscar's PA criteria for sildenafil generally require:

• A confirmed diagnosis of erectile dysfunction or an underlying condition (diabetes, post-surgical nerve damage, cardiovascular disease)
• Patient age 18 or older
• Documentation that the condition is not primarily related to recreational use
• Prescribing clinician's NPI and DEA number

If Oscar denies the PA, federal law gives you the right to an internal appeal, and then an independent external review. The independent external review process is governed by state insurance law and ACA Section 2719, which requires plans to provide external review through an accredited Independent Review Organization (IRO). [10] Approximately 40, 50 percent of external review decisions favor the patient when clinical documentation is complete, based on published IRO outcome data from multiple states.

How Much Does Sildenafil Cost With and Without Oscar Coverage?

With coverage and a met deductible, generic sildenafil on an Oscar Tier 2 formulary typically costs $10, $30 per 30-tablet supply of 50 mg tablets. At Tier 3, that range rises to $30, $60. Before the deductible is met, Oscar pays nothing; you pay the plan's contracted rate with the pharmacy, which is usually lower than the retail cash price.

Without insurance, sildenafil is genuinely inexpensive. The FDA's Orange Book lists more than 20 approved generic manufacturers. [11] As of early 2025, GoodRx and Cost Plus Drugs (Mark Cuban's pharmacy) list 30 tablets of sildenafil 20 mg at under $20, and 6 tablets of 50 mg at $15, $25 at major retail pharmacies. For many patients whose Oscar plan excludes sildenafil or whose deductible is high, paying cash through a discount program is cheaper than running it through insurance.

A 2021 JAMA Internal Medicine analysis found that for 23 percent of commonly prescribed generic drugs, the out-of-pocket copay was actually higher than the cash price at major pharmacies, a phenomenon called "insurance overpayment." [12] Sildenafil is one of the drugs most likely to fall into that category. Asking the pharmacist to run both a cash-pay comparison and an insurance-pay comparison before finalizing any fill is a practical step.

Sildenafil's Clinical Evidence Base: Why Coverage Matters

Sildenafil inhibits phosphodiesterase type 5 (PDE5), an enzyme that degrades cyclic GMP in penile smooth muscle. By blocking PDE5, sildenafil maintains elevated cGMP levels, promoting smooth muscle relaxation and arterial inflow during sexual stimulation. This mechanism was first published in the New England Journal of Medicine in 1996. [13]

The key Phase 3 registration trial for Viagra, published in the New England Journal of Medicine in 1998 (N=532 men with ED of various etiologies), showed that 69 percent of attempts at sexual intercourse were successful in the sildenafil group versus 22 percent in the placebo group (P<0.001). [14] Doses studied were 25 mg, 50 mg, and 100 mg taken 30 to 60 minutes before activity. The 100 mg dose produced the highest response rates and was associated with transient flushing, headache, and visual disturbances in a minority of participants.

A 2018 Cochrane systematic review of 82 randomized trials (N=23,305 men) confirmed sildenafil's superiority over placebo for ED, with a risk ratio for successful intercourse of 2.25 (95% CI 2.02, 2.50) at standard doses. [15] Adverse events were predominantly mild and transient. This evidence base is why professional societies, including the American Urological Association and the American College of Cardiology, now recommend PDE5 inhibitors as the first-line oral therapy for ED in most patients, including those with stable cardiovascular disease. [16]

ED, Cardiovascular Disease, and Why Insurers Should Care

Erectile dysfunction is increasingly recognized as an early marker of cardiovascular disease, not simply a quality-of-life issue. A 2018 meta-analysis published in the Journal of the American Heart Association (N=154,794) found that men with ED had a 43 percent higher risk of cardiovascular events compared with men without ED (HR 1.43 to 95% CI 1.27, 1.61). [17] ED often precedes clinically apparent coronary artery disease by 3 to 5 years, giving clinicians a window to intervene on modifiable cardiovascular risk factors.

This cardiovascular connection provides another argument for medical necessity when seeking PA. A clinician who documents that sildenafil is being prescribed in a patient with hypertension, dyslipidemia, or pre-diabetes, and who references the cardiovascular risk literature, frames the request as preventive cardiovascular care as much as sexual health treatment.

The Princeton Consensus III guidelines, published in the Mayo Clinic Proceedings in 2012, stratified patients by cardiovascular risk and concluded that most men with ED are low-to-intermediate cardiovascular risk and can safely use PDE5 inhibitors. [18] Oscar's PA reviewers are familiar with these guidelines, and citing them in the PA letter adds clinical credibility.

Contraindications and Safety Considerations Oscar's PA Process Screens For

Oscar's utilization management criteria screen for absolute contraindications to sildenafil before approving coverage. The most important is concurrent use of organic nitrates (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) or nitric oxide donors, because the combination can cause severe, potentially fatal hypotension. The FDA's prescribing information for sildenafil carries a black-box-equivalent warning for this interaction. [19]

Additional contraindications include:

• Retinitis pigmentosa (rare hereditary retinal disease)
• Recent stroke or myocardial infarction (within 6 months)
• Severe hepatic impairment (Child-Pugh Class C)
• Baseline systolic BP <90 mmHg or >170 mmHg
• Concurrent use of ritonavir or other strong CYP3A4 inhibitors at high doses

Patients on alpha-blockers for BPH or hypertension may use sildenafil but require a dose reduction and a time separation of at least 4 hours to avoid additive hypotension. The AUA guideline on ED management provides specific dose-adjustment tables. [5] Oscar's PA reviewers use similar clinical criteria, so a PA letter that proactively addresses contraindications and explains why they do not apply to the specific patient improves approval likelihood.

How to Check Your Specific Oscar Plan's Sildenafil Coverage in 2025

No two Oscar plans are identical. Coverage depends on the state, plan year, whether the plan is individual marketplace, employer-sponsored, or small group, and what formulary tier the employer's benefits consultant negotiated. Four concrete steps will give you a definitive answer in under 15 minutes:

Step 1. Log into your Oscar Health member portal at hioscar.com. Manage to "Benefits" and then "Drug Coverage." Enter "sildenafil" in the drug search tool. The tool shows tier, PA requirements, and quantity limits for your specific plan.

Step 2. Download your plan's Evidence of Coverage (EOC) document from the same portal. Search the PDF for "sildenafil," "Viagra," and "sexual dysfunction." Any exclusion language will appear verbatim in the EOC.

Step 3. Call the member services number on the back of your Oscar ID card and ask specifically: "Is sildenafil citrate 50 mg on my current formulary, and does it require prior authorization?" Document the representative's name, date, and reference number for the call.

Step 4. Ask your prescribing clinician to submit a PA request through Oscar's provider portal (or via fax using Oscar's PA request form) before the prescription is sent to the pharmacy. Starting the PA before the pharmacy runs the claim prevents rejected claims and wasted pharmacy trips.

The FDA's drug database can confirm sildenafil's current approved indications and reference labeling if any clinical questions arise during the PA process. [20]

Telehealth Platforms and Oscar's Coverage of ED Consultations

Oscar offers a built-in virtual care program called "Oscar Care" that connects members with licensed clinicians by video or text. ED consultations through Oscar Care are generally covered as primary care visits, subject to normal copay rules ($0, $50 depending on the plan). The clinician can evaluate ED, order baseline labs (testosterone, fasting glucose, lipid panel), and submit a sildenafil PA request all within the same telehealth encounter.

A 2020 study in the Journal of Sexual Medicine found that telehealth-based ED care produced equivalent patient satisfaction and comparable medication adherence rates to in-person urology visits, with a mean consultation time of 14.3 minutes. [21] For men who are reluctant to discuss ED in a traditional clinical setting, the telehealth pathway through Oscar Care reduces friction and accelerates access to treatment.

The American Urological Association's 2021 telehealth position statement specifically endorses virtual evaluation of uncomplicated ED as clinically appropriate when no acute urological emergency is present. [22] This endorsement supports billing the Oscar Care visit as a legitimate medical encounter rather than a lifestyle consultation.

Alternatives If Oscar Denies Sildenafil Coverage

If Oscar denies coverage for sildenafil after PA and appeal, four practical alternatives exist:

Generic sildenafil cash pay. As described above, Mark Cuban's Cost Plus Drugs platform sells 30 tablets of sildenafil 20 mg for under $20 without insurance. Four 20 mg tablets approximate a 80 mg dose, though this off-label dosing should be discussed with a clinician first.

Tadalafil (Cialis generic). Generic tadalafil, FDA-approved for both ED and BPH, costs $15, $40 for a 30-day supply at many pharmacies and may be on a different Oscar formulary tier than sildenafil. [23] Some patients tolerate tadalafil's 36-hour window of effect better than sildenafil's 4, 6-hour window.

Vardenafil or avanafil. Both are FDA-approved PDE5 inhibitors. Vardenafil (generic Levitra) is less expensive than brand avanafil (Stendra) and may appear at a different formulary tier. [24]

Testosterone optimization. In men with documented hypogonadism (total testosterone <300 ng/dL on two fasting morning measurements, per Endocrine Society criteria), treating testosterone deficiency with TRT often improves erectile function independently. [25] Oscar covers TRT when hypogonadism is medically documented, and testosterone optimization may restore PDE5 inhibitor responsiveness in men who previously had a suboptimal response.